Action Changement Date
Alnylam Pharmaceuticals USD 105.91M 8.8M 2026-09
Amgen USD 6.39B 169M 2026-09
Bayer EUR 11.97B 43M 2026-06
BioCryst Pharmaceuticals USD 13.74M 7.68M 2026-09
Biogen USD 2.22B 159.9M 2026-09
BioMarin Pharmaceutical USD 1.8B 13.54M 2026-09
Cipla INR 67.78B 1.82B 2026-09
Clal Biotechnology ILS 4.44M 0 2021-03
CSL USD 6.47B 327M 2025-06
Gilead Sciences USD 1.9B 57M 2026-09
GlaxoSmithKline GBP 6.28B 125M 2026-06
Grifols EUR 3.56B 63.19M 2024-12
Ionis Pharmaceuticals USD 28.58M 22.26M 2026-09
J&J USD 15.38B 233M 2026-09
Karyopharm Therapeutics USD 4.04M 72K 2025-12
Merck USD 6.16B 43M 2026-09
Novartis USD 6.1B 116M 2026-09
Omeros USD 712K 266K 2021-09
Pfizer USD 10.02B 77M 2026-09
Roche Holding CHF 7.6B 9M 2025-06
Sanofi EUR 24.12B 620M 2026-06
Sarepta Therapeutics USD 876.12M 28.15M 2026-09
Ultragenyx Pharmaceutical USD 59M 0 2026-09
Vertex Pharmaceuticals USD 2.25B 480.2M 2026-09